Johnson & Johnson is working with Bristol-Myers Squibb Co to develop a treatment for hepatitis C. The strategy is to block different proteins than the traditional treatments have. Testing for the new drug will begin in the first half of 2012. A couple of of other pharmaceutical companies are also working on a hepatitis C treatment.
Human Biology 1010 Blog
Saturday, December 3, 2011
Developing Hepatitis C Treatments
Johnson & Johnson is working with Bristol-Myers Squibb Co to develop a treatment for hepatitis C. The strategy is to block different proteins than the traditional treatments have. Testing for the new drug will begin in the first half of 2012. A couple of of other pharmaceutical companies are also working on a hepatitis C treatment.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment